Olanzapine pamoate (olanzapine long-acting injection [OLAI]; Zypadhera; Zyprexa Relprevv) is the intramuscular depot formulation of the atypical antipsychotic olanzapine. In two pivotal, double-blind clinical trials of 8 or 24 weeks' duration, the efficacy of recommended dosages of OLAI injected ...
November 10, 2009 (Las Vegas, Nevada) — A long-acting injection form of the antipsychotic drug olanzapine (Eli Lilly & Co) offers efficacy that is consistent with oral administration of the drug and similar to that of haloperidol, and provides the extra benefit of a longer-term treatment, ...
Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell DP: Olanzapine long-acting injection for the maintenance treatment of schizophrenia: a 24-week, randomized, double-blind trial. Am J Psychiatry; in press.Detke H, McDonnell D, Kane J, Naber D, Sethuraman G, ...
Olanzapine long-acting injection: a review of its use in the treatment of schizophrenia. Olanzapine pamoate (olanzapine long-acting injection [OLAI]; Zypadhera庐; Zyprexa庐 Relprevv鈩 ) is the intramuscular depot formulation of the atypical anti... JE Frampton - 《Drugs》 被引量: 90发表: 2010...
Witte MM, Case MG, Schuh KJ, et al. Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia. Curr Med Res Opin. 2012;28(3):315–23. McDonnell DP, Kryzhanovskaya LA, Zhao F, et al. Comparison of metabolic changes in patients wit...
Long-acting injectable (LAI) forms of antipsychotics allow for rapid identification of non-adherence, obviate the need for the patient to take the medication on a daily basis and increase adherence to some significant degree. Eli Lilly has developed a long-acting depot formulation of olanzapine, ...
Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses. Neuropsychiatr Dis Treat. ... C Antonio,...
Olanzapine pamoate (olanzapine long-acting injection [OLAI]; Zypadhera; Zyprexa Relprevv) is the intramuscular depot formulation of the atypical antipsycho... James,E.,Frampton - 《Drugs》 被引量: 34发表: 2010年 Olanzapine Long-Acting Injection Olanzapine pamoate (olanzapine long-acting injection ...
The most commonly used oral antipsychotics were risperidone (0.5–7 mg/day), quetiapine (65–1200 mg/day), and olanzapine (2–25 mg/day). Conclusions Using RLAI reduces the severity of disease in more difficult patients. 展开 ...
Patient and health care provider perspectives on long acting injectable antipsychotics in schizophrenia and the introduction of olanzapine long-acting injection. J Cent Nerv Syst Dis. 2011;3:107. PubMed Central Google Scholar Emami J. In vitro–in vivo correlation: from theory to applications. J...